TD Asset Management Inc. Has $95.81 Million Holdings in CME Group Inc. (NASDAQ:CME)

TD Asset Management Inc. lowered its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 1.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 412,551 shares of the financial services provider's stock after selling 7,858 shares during the quarter. TD Asset Management Inc. owned about 0.11% of CME Group worth $95,807,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its holdings in CME Group by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock worth $7,952,273,000 after acquiring an additional 326,623 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider's stock valued at $1,823,964,000 after purchasing an additional 142,692 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $871,063,000. Janus Henderson Group PLC raised its position in CME Group by 17.8% in the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider's stock worth $554,707,000 after purchasing an additional 380,071 shares during the last quarter. Finally, Capital Wealth Planning LLC lifted its holdings in CME Group by 69.2% during the 4th quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock worth $565,671,000 after buying an additional 996,498 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. boosted their target price on CME Group from $209.00 to $212.00 and gave the stock an "underweight" rating in a research report on Thursday, February 13th. Citigroup downgraded CME Group from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research report on Monday, March 10th. Piper Sandler upped their target price on shares of CME Group from $250.00 to $258.00 and gave the company an "overweight" rating in a report on Tuesday, January 7th. Finally, Morgan Stanley upped their price objective on CME Group from $256.00 to $263.00 and gave the company an "equal weight" rating in a research note on Wednesday, February 19th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $238.93.

Insider Buying and Selling at CME Group

In other news, COO Suzanne Sprague sold 1,500 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock worth $6,871,496 over the last three months. Corporate insiders own 0.30% of the company's stock.

CME Group Price Performance

NASDAQ:CME traded up $0.37 during trading hours on Friday, reaching $262.22. 1,736,117 shares of the company were exchanged, compared to its average volume of 2,049,091. The business has a 50 day moving average of $249.65 and a 200 day moving average of $235.75. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $267.91. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company has a market capitalization of $94.49 billion, a P/E ratio of 27.12, a P/E/G ratio of 6.76 and a beta of 0.53.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping analysts' consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were given a dividend of $1.25 per share. This is a positive change from CME Group's previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. This represents a $5.00 annualized dividend and a dividend yield of 1.91%. CME Group's dividend payout ratio (DPR) is currently 51.71%.

CME Group declared that its board has initiated a stock buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board of directors believes its stock is undervalued.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.